Mihail Obrocea

2021

In 2021, Mihail Obrocea earned a total compensation of $2.1M as Chief Medical Officer at MAIA Biotechnology.

Compensation breakdown

Bonus$57,731
Option Awards$1,907,411
Salary$162,500
Other$18,344
Total$2,145,986

Obrocea received $1.9M in option awards, accounting for 89% of the total pay in 2021.

Obrocea also received $57.7K in bonus, $162.5K in salary and $18.3K in other compensation.

Rankings

In 2021, Mihail Obrocea's compensation ranked 5,786th out of 12,415 executives tracked by ExecPay. In other words, Obrocea earned more than 53.4% of executives.

ClassificationRankingPercentile
All
5,786
out of 12,415
53rd
Division
Manufacturing
2,453
out of 5,505
55th
Major group
Chemicals And Allied Products
1,064
out of 2,375
55th
Industry group
Drugs
947
out of 2,096
55th
Industry
Pharmaceutical Preparations
680
out of 1,546
56th
Source: SEC filing on April 19, 2023.

Obrocea's colleagues

We found three more compensation records of executives who worked with Mihail Obrocea at MAIA Biotechnology in 2021.

2021

Joseph McGuire

MAIA Biotechnology

Chief Financial Officer

2021

Vlad Vitoc

MAIA Biotechnology

Chief Executive Officer

2021

Sergei Gryaznov

MAIA Biotechnology

Chief Scientific Officer

News

In-depth

You may also like